学会発表（国際）

  • Kobayashi A, Hasegawa K, Saiura A, Takayama T, Miyagawa S, Yamamoto J, Bandai Y, Teruya M, Yoshimi F, Kawasaki S, Koyama H, Oba M, Takahashi M, Mizunuma N, Matsuyama Y, Watanabe T, Makuuchi M, Kokudo N. A randomized controlled trial evaluating efficacy of adjuvant oral uracil-tegafur (UFT) with leucovorin (LV) after resection of colorectal cancer liver metastases: The UFT/LV study. 50th American Society of Clinical Oncology (ASCO) annual meeting.(abstract 3584). May 30-June 3, 2014, McCormick Place, Chicago, Illinois.
  • Nakamura M, Muramatsu T, Yokoi H, Okada H, Ochiai M, Suwa S, Matsuyama Y, Nanto S. J-DESsERT 3-Year Outcomes: Largest randomized trial stratified by diabetes mellitus presence, comparing sirolimus and paclitaxel eluting stents. Transcatheter Cardiovascular Therapeutics (TCT). October 27-November 1, 2013, The Moscone Center San Francisco, CA, USA.
  • Naito Y, Ohashi Y, Yokota I, Watanabe T, Iwata H, Ohsumi S, Ohno S, Hozumi Y, Yamamoto S, Takahashi M, Aihara T, Mukai H. Low body mass index (BMI) is associated with poor survival in Japanese patients with early breast cancer; an exploratory analysis of prospective randomized phase III trials N-SAS BC02 and 03. 2014 CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX, Dec 13, 2014. Session # P6-08-21.
  • Takeuchi Y, Higa S, Endo A, Matsui K, Watanabe S. The Risk of Acute Asthmatic Attacks Associated with Different Dosage Forms of Non-Steroidal Anti-Inflammatory Drugs: a Self-Controlled Case Series Study (poster presentation). 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Taipei. Oct 2014.
  • Nomura S, Shinozaki T, Hamada C. A new framework using g-estimation for placebo-controlled randomized phase 3 trials with extensive crossovers for biomarker-driven molecularly targeted oncology agents. 35th Annual Conference of the International Society for Clinical Biostatistics, Vienna, Austria. Aug 2014. Abstract C.25.5.
  • Shinozaki T, Matsuyama Y. Robust and efficient estimation of structural nested mean models in randomized trials with partial compliance using generalized method of moments. The XXVIIth International Biometric Conference, Florence, Italy. July 10, 2014. Poster Group 2, Abstract 35.
  • Yoshimura A, Iwata H, Hayashi T, Kobayashi N, Saito K, Tsuneizumi M, Sawaki M, Hattori M, Nakada T, Yokota I, Toyama T. A randomized phase II study evaluating the use of prydoxine to prevent hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer. 2014 ASCO annual meeting, Chicago, IL, Jun 1, 2014. J Clin Oncol 32:5s, 2014 (suppl; abstr 9610).

TOP